• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Long-term Persistence of Dysplastic Features in Patients with Acute Promyelocytic Leukemia Treated with All-trans Retinoic Acid and Arsenic Trioxide.

作者信息

Santinelli Enrico, Pascale Maria Rosaria, Guarnera Luca, Savi Arianna, Mallegni Flavia, Catanoso Maria Luigia, Gurnari Carmelo, Maurillo Luca, Voso Maria Teresa, Fenu Susanna

机构信息

Department of Biomedicine and Prevention, PhD program in immunology, molecular medicine, and applied biotechnologies, University of Rome Tor Vergata, Rome, 00133, Italy.

Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200 - 00128 Roma, Italy.

出版信息

Mediterr J Hematol Infect Dis. 2025 May 1;17(1):e2025038. doi: 10.4084/MJHID.2025.038. eCollection 2025.

DOI:10.4084/MJHID.2025.038
PMID:40375910
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12081039/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8184/12081039/97f6d9e5da36/mjhid-17-1-e2025038f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8184/12081039/97f6d9e5da36/mjhid-17-1-e2025038f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8184/12081039/97f6d9e5da36/mjhid-17-1-e2025038f1.jpg

相似文献

1
Long-term Persistence of Dysplastic Features in Patients with Acute Promyelocytic Leukemia Treated with All-trans Retinoic Acid and Arsenic Trioxide.接受全反式维甲酸和三氧化二砷治疗的急性早幼粒细胞白血病患者发育异常特征的长期持续存在
Mediterr J Hematol Infect Dis. 2025 May 1;17(1):e2025038. doi: 10.4084/MJHID.2025.038. eCollection 2025.
2
Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.三氧化二砷在治疗新诊断的急性早幼粒细胞白血病中是必需的。法国-比利时-瑞士 APL 组对一项随机试验（APL2006）的分析。
Haematologica. 2018 Dec;103(12):2033-2039. doi: 10.3324/haematol.2018.198614. Epub 2018 Jul 19.
3
Addition of Arsenic Trioxide into Induction Regimens Could Not Accelerate Recovery of Abnormality of Coagulation and Fibrinolysis in Patients with Acute Promyelocytic Leukemia.急性早幼粒细胞白血病患者诱导治疗方案中加入三氧化二砷不能加速凝血和纤溶异常的恢复。
PLoS One. 2016 Jan 26;11(1):e0147545. doi: 10.1371/journal.pone.0147545. eCollection 2016.
4
Tocotrienols-enriched Self-nanoemulsifying Drug Delivery System Enhances the Antileukemic Activity of All-trans Retinoic Acid but not Electrocardiogram Alterations Evoked by Its Combination with Arsenic Trioxide.富含生育三烯酚的自纳米乳化药物递送系统增强了全反式维甲酸的抗白血病活性，但不增强其与三氧化二砷联合引起的心电图改变。
AAPS PharmSciTech. 2023 Mar 14;24(3):79. doi: 10.1208/s12249-023-02531-w.
5
Two successful deliveries of healthy children by a young woman diagnosed and treated during induction and relapsed therapy for acute promyelocytic leukemia.一位年轻女性被诊断出患有急性早幼粒细胞白血病，并在诱导缓解和复发治疗期间接受了治疗，随后成功产下了两个健康的孩子。
J Oncol Pharm Pract. 2020 Dec;26(8):2034-2037. doi: 10.1177/1078155220915764. Epub 2020 Apr 11.
6
[Effects of combination therapy with all-trans retinoic acid and arsenic trioxide on acute promyelocytic leukemia].全反式维甲酸与三氧化二砷联合治疗对急性早幼粒细胞白血病的影响
Ai Zheng. 2004 Apr;23(4):430-4.
7
Leucocytosis during all-trans retinoic acid and arsenic trioxide treatment in acute promyelocytic leukaemia.全反式维甲酸和三氧化二砷治疗急性早幼粒细胞白血病时的白细胞增多。
Br J Haematol. 2024 Nov;205(5):1672-1673. doi: 10.1111/bjh.19763. Epub 2024 Sep 15.
8
Efficacy and the Adverse Effects of Oral Versus Intravenous Arsenic for Acute Promyelocytic Leukemia: A Meta-Analysis of Randomized-Controlled Studies.口服与静脉用砷剂治疗急性早幼粒细胞白血病的疗效和不良反应：一项随机对照研究的荟萃分析。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820937008. doi: 10.1177/1533033820937008.
9
Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial.口服砷剂联合维甲酸与静脉用砷剂联合维甲酸治疗非高危急性早幼粒细胞白血病的非劣效性、随机、3 期临床试验。
Lancet Oncol. 2018 Jul;19(7):871-879. doi: 10.1016/S1470-2045(18)30295-X. Epub 2018 Jun 5.
10
Severe Wernicke encephalopathy and acute pancreatitis due to all-trans-retinoic acid and arsenic trioxide during treatment of acute promyelocytic leukaemia: a case report.全反式维甲酸和三氧化二砷治疗急性早幼粒细胞白血病期间导致的严重韦尼克脑病和急性胰腺炎：一例报告
J Int Med Res. 2020 Sep;48(9):300060520959487. doi: 10.1177/0300060520959487.

本文引用的文献

1
Acute promyelocytic leukemia: long-term outcomes from the HARMONY project.急性早幼粒细胞白血病：HARMONY项目的长期结果
Blood. 2025 Jan 9;145(2):234-243. doi: 10.1182/blood.2024026186.
2
Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy.三氧化二砷与化疗治疗急性早幼粒细胞白血病患者的长期生活质量。
Blood Adv. 2021 Nov 9;5(21):4370-4379. doi: 10.1182/bloodadvances.2021004649.
3
[Therapy-related myeloid neoplasms after successful treatment for acute promyelocytic leukemia: a report of four cases and literature review].
急性早幼粒细胞白血病成功治疗后发生的治疗相关髓系肿瘤：4例报告及文献复习
Zhonghua Xue Ye Xue Za Zhi. 2019 Dec 14;40(12):1008-1014. doi: 10.3760/cma.j.issn.0253-2727.2019.12.007.
4
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial.全反式维甲酸和三氧化二砷治疗非高危急性早幼粒细胞白血病的长期结果：APL0406意大利-德国随机试验的更新
Leukemia. 2020 Mar;34(3):914-918. doi: 10.1038/s41375-019-0589-3. Epub 2019 Oct 14.
5
Bone Marrow Findings in Patients With Acute Promyelocytic Leukemia Treated With Arsenic Trioxide.砷剂治疗急性早幼粒细胞白血病患者的骨髓发现。
Am J Clin Pathol. 2019 Oct 7;152(5):675-685. doi: 10.1093/ajcp/aqz087.
6
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.急性早幼粒细胞白血病的治疗：欧洲白血病网专家小组的最新建议。
Blood. 2019 Apr 11;133(15):1630-1643. doi: 10.1182/blood-2019-01-894980. Epub 2019 Feb 25.
7
Secondary clonal hematologic neoplasia following successful therapy for acute promyelocytic leukemia (APL): A report of two cases and review of the literature.急性早幼粒细胞白血病（APL）成功治疗后发生的继发性克隆性血液系统肿瘤：两例报告并文献复习
Leuk Res Rep. 2018 Apr 16;9:65-71. doi: 10.1016/j.lrr.2018.04.005. eCollection 2018.
8
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial.维甲酸和三氧化二砷与维甲酸和化疗治疗非高危急性早幼粒细胞白血病的疗效比较：意大利-德国 APL0406 随机试验的最终结果。
J Clin Oncol. 2017 Feb 20;35(6):605-612. doi: 10.1200/JCO.2016.67.1982. Epub 2016 Oct 31.
9
Incidence of secondary neoplasms in patients with acute promyelocytic leukemia treated with all-trans retinoic acid plus chemotherapy or with all-trans retinoic acid plus arsenic trioxide.接受全反式维甲酸联合化疗或全反式维甲酸联合三氧化二砷治疗的急性早幼粒细胞白血病患者继发肿瘤的发生率。
Leuk Lymphoma. 2015 May;56(5):1342-5. doi: 10.3109/10428194.2014.953143. Epub 2014 Nov 3.
10
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes.最小形态学标准定义骨髓增生异常：WHO 骨髓增生异常综合征分类临床实施的基础。
Leukemia. 2015 Jan;29(1):66-75. doi: 10.1038/leu.2014.161. Epub 2014 May 20.